A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants
Research output: Contribution to journal › Journal article › Research › peer-review
The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial.
| Original language | English |
|---|---|
| Journal | New England Journal of Medicine |
| Volume | 367 |
| Issue number | 24 |
| Pages (from-to) | 2284-95 |
| Number of pages | 12 |
| ISSN | 0028-4793 |
| DOIs | |
| Publication status | Published - 2012 |
ID: 43233798